Tozorakimab COPD Mechanistic Study - The MAB Trial

• Research type

  Research Study

• Full title

  Publication of this data is currently deferred.

• IRAS ID

  1011840

• Contact name

  Christopher Brightling

• Contact email

  Ceb17@leicester.ac.uk

• Sponsor organisation

  Publication of this data is currently deferred.

• ISRCTN Number

  ISRCTN35638452

• Research summary

  Publication of this data is currently deferred.

• REC name

  London - South East Research Ethics Committee

• REC reference

  25/LO/0628

• Date of REC Opinion

  9 Oct 2025

• REC opinion

  Further Information Favourable Opinion